» Articles » PMID: 37297526

ResQ Family: Respiratory Syncytial Virus (RSV) Infection in Infants and Quality of Life of Families-Study Protocol of a Multi-Country Family Cohort Study

Overview
Publisher MDPI
Date 2023 Jun 10
PMID 37297526
Authors
Affiliations
Soon will be listed here.
Abstract

(1) Respiratory syncytial virus (RSV) infection in infants not only affects the child itself, but also their families. Nevertheless, information on the overall impact is scarce. A comprehensive caregiver-specific approach covering essential (health) dimensions and relevant stakeholders was initiated under the ResQ Family study conducted in Germany, France, Italy and Sweden. The primary objective is to investigate the health-related quality of life of parents and/or caregivers of children (<24 months) hospitalised for RSV. (2) Each participant completes an online questionnaire disseminated via social media and printed material in hospitals. Using the PedsQL FIM as well as further self-designed questions, parent and patient characteristics as well as potential stressors and preventive factors are recorded at baseline and after six weeks. Multivariate regression models with health-related quality of life as main outcome parameter will be conducted. (3) The study is currently in the recruitment process. A full analysis will be performed once the data collection phase is complete. First results are to be expected in late 2023. (4) Publishing the results in the form of scientific papers but also non-scientific (information) material will help us raise awareness for RSV and the importance of prevention among healthcare professionals, patient representatives and decision-makers.

Citing Articles

The Multifaceted Burden of Respiratory Syncytial Virus (RSV) Infections in Young Children on the Family: A European Study.

Trautmannsberger I, Plagg B, Adamek I, Mader S, De Luca D, Esposito S Infect Dis Ther. 2024; 13(7):1531-1573.

PMID: 38767780 PMC: 11219685. DOI: 10.1007/s40121-024-00989-0.

References
1.
Li Y, Wang X, Blau D, Caballero M, Feikin D, Gill C . Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022; 399(10340):2047-2064. PMC: 7613574. DOI: 10.1016/S0140-6736(22)00478-0. View

2.
Lapillonne A, Regnault A, Gournay V, Gouyon J, Gilet H, Anghelescu D . Impact on parents of bronchiolitis hospitalization of full-term, preterm and congenital heart disease infants. BMC Pediatr. 2012; 12:171. PMC: 3506487. DOI: 10.1186/1471-2431-12-171. View

3.
Mao Z, Li X, Dacosta-Urbieta A, Billard M, Wildenbeest J, Korsten K . Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe. Vaccine. 2023; 41(16):2707-2715. DOI: 10.1016/j.vaccine.2023.03.024. View

4.
Chew L, Bradley K, Boyko E . Brief questions to identify patients with inadequate health literacy. Fam Med. 2004; 36(8):588-94. View

5.
Boivin A, Richards T, Forsythe L, Gregoire A, LEsperance A, Abelson J . Evaluating patient and public involvement in research. BMJ. 2018; 363:k5147. DOI: 10.1136/bmj.k5147. View